Your search returned 9 results.

Sort
Results
1.
Trastuzumab-Induced Cardiomyopathy. [Review] MedStar authors:
  • Barac, Ana
  • Gates, Emily
PMID:
  • 31587782
Year: 2019
Citation:
  • Cardiology Clinics. 37(4):407-418, 2019 Nov.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Barac A, Barish R, Gates E
2.
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 35430509
Year: 2022
Citation:
  • Cancer Treatment Reviews. 106:102378, 2022 May.
Department:
  • Associate Dean for Research Development
  • MedStar Health
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Andre F, Bartholmai BJ, Conte P, Kato T, Lancaster LH, Li BT, Naidoo J, Nicholson AG, Nishino M, Powell CA, Schumacher-Wulf E, Shitara K, Swain SM, Tsurutani J
3.
Intermittent left bundle branch block and acute heart failure in trastuzumab-induced cardiotoxicity. MedStar authors:
  • Masson, Ravi
PMID:
  • 32723779
Year: 2020
Citation:
  • BMJ Case Reports. 13(7), 2020 Jul 28.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Internal Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bakhshi H, Haddad TM, Masson R
4.
Breast Cancer and Heart Failure. [Review] MedStar authors:
  • Barac, Ana
PMID:
  • 30449381
Year: 2019
Citation:
  • Heart Failure Clinics. 15(1):65-75, 2019 Jan.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Almuwaqqat Z, Barac A, Meisel JL, Parashar S
5.
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. MedStar authors:
  • Swain, Sandra M
PMID:
  • 32371537
Year: 2020
Citation:
  • Clinical Cancer Research. 26(16):4233-4241, 2020 08 15.
Institution:
  • MedStar Health
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Brauer HA, Geyer CE Jr, Goerlitz DS, Harris BT, Lucas PC, Mamounas EP, Rastogi P, Ren Y, Robidoux A, Swain SM, Tang G, Wolmark N
6.
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
  • Swain, Sandra M
  • Zapas, John L
PMID:
  • 29072977
Year: 2017
Citation:
  • Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
7.
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 34890214
Year: 2022
Citation:
  • Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
8.
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Cunningham, A
  • Gallagher, Christopher
  • Hofmeyer, Mark
  • Srichai, M B
  • Swain, Sandra M
PMID:
  • 30852761
Year: 2019
Citation:
  • Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
  • MedStar Health
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
9.
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 28314836
Year: 2017
Citation:
  • Oncologist. 22(5):518-525, 2017 May
Institution:
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
Pages

Powered by Koha